CD34 and neoplasm: The number of CD34+ tumor vessels did not differ between EPCRLow/Low and EPCRLow/WT tumors, although quantification of CD34+ areas indicated a somewhat increased vessel size in EPCRLow/Low tumors (Fig. S1D, E).